With the New York cannabis market projected to surpass $5 billion by 2027, this acquisition positions CBDL for exponential revenue growth and expanded market dominance.
The global cannabis market size was valued at USD 43.72 billion in 2022 and is projected to grow from USD 57.18 billion in 2023 to USD 444.34 billion by 2030, exhibiting a CAGR of 34.03% during the forecast...
CBD Life Sciences propels its expansion with a major MOU, positioning the company for multi-million-dollar growth in the booming $14.6 billion adaptogens market.
The targeted acquisition is estimated to have a business value of approximately $10 million and projected 2024 gross revenues of up to $4.5 million
SCOTTSDALE, AZ / ACCESSWIRE / July 16, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL), through its dynamic subsidiary The CBD Vault Inc, is thrilled to announce a transformative partnership with Sunset...
SCOTTSDALE, AZ / ACCESSWIRE / June 27, 2024 / CBD Life Sciences Inc. (OTC PINK:CBDL) through its wholly owned subsidiary, The CBD Vault Inc. a leading innovator in the CBD industry, is thrilled to announce...
SCOTTSDALE, AZ / ACCESSWIRE / July 14, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company is proud to launch its Delta-8...
SCOTTSDALE, AZ / ACCESSWIRE / June 30, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announces today that the company has begun starting a New...
SCOTTSDALE, AZ / ACCESSWIRE / May 19, 2022 / Today CBD Life Sciences (OTC PINK:CBDL) through its wholly owned subsidiary, LBC Bioscience Inc. announced today that the company is set to attend the White...